Center for Research Strategy (CRS)

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Center for Research Strategy (CRS) is a science-based office that collaboratively develops recommendations for addressing scientific opportunities, monitors the direction and application of the NCI’s scientific knowledge and resources, and identifies research funding gaps.

The Center for Research Strategy responsibilities are to:
  • Synthesize input from NCI leadership and external stakeholders to inform priority initiatives
  • Identify scientific opportunities within priority initiatives
  • Coordinate development of programs across the NCI to address opportunities
  • Conduct portfolio analysis to support priority setting and scientific strategic planning
  • Collect and analyze data to identify research accomplishments
  • Recommend strategies for allocating resources effectively


The NCI Annual Plan and Budget Proposal

Commonly called the Bypass Budget, this planning, budget, and policy document is sent to the President and Congress each fiscal year to inform them of the NCI’s best professional judgment on the funding needed to make the most rapid progress against cancer. CRS convenes stakeholders from across NCI to gather ideas and build a vision in order to compose the plan. CRS collaborates with OBF, OGCR, and OCPL to formulate a budget and communicate the plan.

Cancer Research Health Disparities

The CRS works across the NCI Divisions, Offices, and Centers to identify scientific research opportunities and coordinate initiatives to reduce cancer health disparities through basic and applied research. This work facilitates the identification of which groups of people may be more or less likely to develop cancer, experience cancer-related health problems, or die from cancer than other groups of people.

NCI Firewood Sessions

CRS convenes a series of discussions with NCI staff that allow NCI leadership to hear their best ideas. This is an opportunity for the community to share ideas about the work NCI is doing, how efforts are organized and ranked, how decisions are made, and how to communicate internally and externally.

Portfolio and Asset Analysis

CRS conducts portfolio and asset analysis for NCI leadership to inform policy and decision making and program management. CRS also provides consultation and other support to NCI staff to: identify gaps, opportunities, and emerging research areas; review the breadth and depth of scientific programs; assess the cancer research workforce landscape; and identify scientific accomplishments.

International Cancer Research Partnership

CRS leads NIH participation in the International Cancer Research Partnership, a consortium of worldwide cancer funding organizations dedicated to enhancing cancer funding information. This increases knowledge of the array of research that international cancer research organizations are supporting.

Program Evaluation

CRS consults with the Office of the Director and other Divisions, Offices, and Centers on evaluation-related projects, analyses, and requests. In addition, CRS conducts evaluation tasks for a limited number of high priority areas.  CRS represents NCI in trans-NIH planning and evaluation-focused efforts.

Planning and Evaluation (P&E)

CRS serves as NCI representative in the NIH Planning & Evaluation (P&E) Officers Committee. As such, CRS functions as liaison between NCI's Divisions, Offices, and Centers (DOCs) and NIH Office of the Director (NIH OD) for P&E-related activities. The majority of these activities are law-mandated reports that show the progress of NIH biomedical research programs. The P&E-related activities performed by CRS aid in policy development and adherence, strategic planning, portfolio analysis, program evaluation, and monitoring research progress of NCI and NIH as a whole.

  • Updated: March 24, 2017